[1] Mckellar Q A,Benchaoui H A. Avermectins and milbemycins[J]. Journal of Veterinary Pharmacology & Therapeutics, 1996, 19 (5): 331-351.
[2] Campbell W C, Benz G W. Ivermectin: A review of efficacy and safety[J]. Journal of Veterinary Pharmacology and Therapeutics, 1984, 7(1):1-16.
[3] 范琳玉, 余安国, 李贤均, 等. 阿维菌素催化选择加氢合成伊维菌素研究[J].分子催化, 2003, 17 (1): 6-9.
[4] 扈洪波, 朱蓓蕾, 李俊锁. 阿维菌素类药物的研究进展[J]. 畜牧兽医学报, 2000, 31 (6): 520-529.
[5] Lespine A, Martin S, Dupuy J, et al. Interaction of macrocyclic lactones with P-glycoprotein:Structure-affinity relationship[J].European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences,2007,30 (1): 84-85.
[6] 刘耀川, 赵刚, 宁静, 等. 阿维菌素的研究进展[J]. 现代畜牧兽医, 2012,21 (1): 60-62.
[7] 吴仲达, 李光裕, 程霞, 等. 伊维菌素的驱虫应用研究进展[J]. 兽药与饲料添加剂, 2002,7 (2):21-23.
[8] 韩启真, 陈瑞杰, 郑晓云, 等. 伊维菌素治疗人体寄生虫病的研究进展[J]. 中国寄生虫病防治杂志, 2005, 18(5):47-49.
[9] Bishop B F, Bruce C I, Evans N A. Selamectin:A novel broad-spectrum endectocide for dogs and cats[J].Veterinary parasitology, 2000, 91(3/4): 163-176.
[10] 李有业. 寄生虫对伊维菌素的抗药性及其应对措施[J].兽药与饲料添加剂, 2003,8(5):11-12.
[11] 李春生. 伊维菌素片剂对犊牛新蛔虫病的治疗效果观察[J].畜牧兽医杂志,2009,28(5): 117-118.
[12] Lo P K, Fink D W, Williams J B, et al. Pharmacokinetic Studies of Ivermectin:Effects of Formulation[J].Veterinary Resesrch Communications,1985,9(4):251-268.
[13] 陈小军,孙志良,杨惠麟.伊维菌素制剂在动物医学中的研究进展[J]. 湖南畜牧兽医,2005(1): 1-3,11.
[14] Megha, Sawatzki P, Kolter T, et al. Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts) [J]. Biochimica et Biophysica Acta (BBA) - Biomembranes, 2007, 1768 (9): 2205-2212.
[15] Wartewig S, Neubert R H. Properties of ceramides and their impact on the stratum corneum structure: Areview [J]. Skin Pharmacology & Physiology, 2007, 20 (5): 220-229.
[16] 方世平, 杨宝玉. 药剂学促进透皮吸收技术的机制[J]. 中国医院药学杂志, 2000, 20 (12): 750-752.
[17] 刘成, 胡晋红, 朱全刚. 透皮吸收制剂基质的研究进展[J]. 中国新药杂志, 2002, 11 (8): 601-604. |